Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Management of Venous Thromboembolic Events (VTE) in Patients With Hematologic Disorders and Treatment-Induced Thrombocytopenia: A Pilot Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03195010
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:32.093077+00:00
Published At
2019-10-21T00:00:00+00:00
Record Updated At
2019-10-21
Results Posted At
2019-10-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Biphenotypic Leukemia", "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "B-Cell Non-Hodgkin Lymphoma", "Chronic Lymphocytic Leukemia", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Hematologic and Lymphocytic Disorder", "Hematopoietic Cell Transplantation Recipient", "Myelodysplastic Syndrome", "Primary Myelofibrosis", "Secondary Myelofibrosis", "T-Cell Non-Hodgkin Lymphoma", "Thrombocytopenia", "Venous Thromboembolism"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-10-21"
protocolSection.identificationModule.nctId
"NCT03195010"
protocolSection.identificationModule.officialTitle
"Management of Venous Thromboembolic Events (VTE) in Patients With Hematologic Disorders and Treatment-Induced Thrombocytopenia: A Pilot Study"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-10-21"

Study condition terms

  • Acute Biphenotypic Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • B-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)
  • Hematologic and Lymphocytic Disorder (protocolSection.conditionsModule.conditions)
  • Hematopoietic Cell Transplantation Recipient (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Primary Myelofibrosis (protocolSection.conditionsModule.conditions)
  • Secondary Myelofibrosis (protocolSection.conditionsModule.conditions)
  • T-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Thrombocytopenia (protocolSection.conditionsModule.conditions)
  • Venous Thromboembolism (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.